Protective effects of a nicotinamide derivative, isonicotinamide, against streptozotocin-induced β-cell damage and diabetes in mice
- 1 December 2013
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 442 (1-2) , 92-98
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01 DK05827)
- American Diabetes Association (7-08-RA-77)
- Microscopy and Image Analysis Core of Massachusetts General Hospital (P30NS045776)
This publication has 35 references indexed in Scilit:
- SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivityAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- Activation of SIRT1 by Resveratrol Represses Transcription of the Gene for the Cytosolic Form of Phosphoenolpyruvate Carboxykinase (GTP) by Deacetylating Hepatic Nuclear Factor 4αJournal of Biological Chemistry, 2009
- Regulation of Pancreatic Juxtaductal Endocrine Cell Formation by FoxO1Molecular and Cellular Biology, 2009
- Islet β-Cells Deficient in Bcl-xL Develop but Are Abnormally Sensitive to Apoptotic StimuliDiabetes, 2009
- Overexpression of SIRT1 Protects Pancreatic β-Cells Against Cytokine Toxicity by Suppressing the Nuclear Factor-κB Signaling PathwayDiabetes, 2009
- Effect of nicotinamide on early graft failure following intraportal islet transplantationExperimental & Molecular Medicine, 2009
- Insulin Resistance and Progression to Type 1 Diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT)Diabetes Care, 2008
- Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetesNature, 2007
- Sirt1 Regulates Insulin Secretion by Repressing UCP2 in Pancreatic β CellsPLOS Biology, 2005
- Effects of Nicotinamide and Its Isomers on Iron‐induced Renal DamageActa Pathologica Japonica, 1992